|
Re: Long Covid thought to affect half of Covid cases
|
4
|
Resverlogix Corp.
|
Jun 24, 2021 06:56PM
|
|
Re: Rant time...
|
4
|
Resverlogix Corp.
|
Feb 05, 2021 10:37AM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics
|
4
|
Resverlogix Corp.
|
Aug 04, 2020 04:03PM
|
|
Re: Context on Sales Potential for an oral anti-viral & anti-inflammation combo
|
4
|
Resverlogix Corp.
|
Apr 14, 2021 10:51PM
|
|
Violation Report
|
4
|
Resverlogix Corp.
|
Nov 27, 2020 12:50PM
|
|
Re: 10BagR's Violation message from Nov 27
|
4
|
Resverlogix Corp.
|
Dec 04, 2020 07:24AM
|
|
Re: Resverlogix Announces Overnight Marketed Equity Offering
|
4
|
Resverlogix Corp.
|
Jun 08, 2017 05:15PM
|
|
Resverlogix Reports Positive FDA Type B Meeting on Design Issues Relating to a Proposed Phase 2a Kidney Dialysis Trial
|
4
|
Resverlogix Corp.
|
Feb 23, 2017 07:46AM
|
|
Resverlogix Announces Receipt of Notice of Allowance from the United States Patent and Trademark Office
|
4
|
Resverlogix Corp.
|
Mar 15, 2017 08:09AM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics
|
4
|
Resverlogix Corp.
|
Aug 04, 2020 11:07PM
|
|
Re: Reverse Split, the good, bad and in between....
|
4
|
Resverlogix Corp.
|
Aug 14, 2018 12:24AM
|
|
Re: Resverlogix Publishes New Data Highlighting Apabetalone’s Benefit in Non-alcoholic Fatty Liver Disease
|
4
|
Resverlogix Corp.
|
Aug 23, 2022 10:54PM
|
|
Re: Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients
|
4
|
Resverlogix Corp.
|
Jun 13, 2023 05:38PM
|
|
Re: Will RVX be bankrupt?
|
4
|
Resverlogix Corp.
|
Jun 04, 2020 09:44PM
|
|
Re: Fuzyjr
|
4
|
Resverlogix Corp.
|
Aug 22, 2017 12:17PM
|
|
Re: I believe the big/long wait
|
4
|
Resverlogix Corp.
|
Aug 25, 2023 08:49AM
|
|
Re: I believe the big/long wait
|
4
|
Resverlogix Corp.
|
Aug 25, 2023 08:57AM
|
|
Re: RVV insider purchases
|
4
|
Resverlogix Corp.
|
Dec 12, 2022 07:06PM
|
|
Re: Covid
|
4
|
Resverlogix Corp.
|
Aug 12, 2022 05:55PM
|
|
Re: Resverlogix Randomizes First Patient in Taiwan/China Portion of the Phase 3 BETonMACE Clinical Trial
|
4
|
Resverlogix Corp.
|
Jul 10, 2017 08:37AM
|
